Sponsored by:

Naviscan adds Texas client

AuntMinnie.com staff writers
Oct 3, 2010

PET developer Naviscan has added SightLine Health in Houston to its customer list.

The San Diego-based vendor installed a positron emission mammography (PEM) scanner at the breast cancer treatment provider's facility in West Houston.

Related Reading

Naviscan touts PEM study results, September 28, 2010

Naviscan wins Texas PEM install, August 26, 2010

Naviscan touts study on dose for PEM scanner, August 24, 2010

Naviscan touts PEM study, May 26, 2010

Naviscan to export PEM to Colombia, March 30, 2010

Copyright © 2010 AuntMinnie.com

Latest in Nuclear Medicine
Research Money
GT Medical Technologies secures $53M in funding
July 15, 2025
New H3 Tracers Thumbnail
SNMMI: New PET tracers developed for imaging brain disorders
June 21, 2025
Your faster way to answers with Symbia Pro.specta
Sponsored
Your faster way to answers with Symbia Pro.specta
July 9, 2025
Money Pile 400
Positrigo closes $8.5M funding round
June 10, 2025
Related Stories
187x200 Am Logo
Companies
AuntMinnie.com
2010 09 27 09 17 20 380 Asnc Pet Ct Plaque 01 Thumb
Nuclear Medicine
FDG-PET/CT viability scans detect vulnerable aortic plaque
2010 09 16 11 29 19 815 Erlotinib Image Thumb
Nuclear Medicine
PET/CT detects early efficacy of chemo drug in NSCLC patients
Your faster way to answers with Symbia Pro.specta
Sponsor Content
Your faster way to answers with Symbia Pro.specta
More in Nuclear Medicine
GT Medical Technologies secures $53M in funding
By AuntMinnie.com staff writers
Medical device developer GT Medical Technologies has secured $53 million in financing.
July 15, 2025
Research Money
SNMMI: New PET tracers developed for imaging brain disorders
By Will Morton
Two newly developed PET imaging agents are effective for identifying a highly expressed receptor in neurological and psychiatric conditions.
June 21, 2025
New H3 Tracers Thumbnail
Ratio Therapeutics partners with Macrocyclics
By AuntMinnie.com staff writers
The agreement will enable access to Macropa in Japan, Canada, Australia, and a majority of Europe, according to Ratio.
June 13, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
Positrigo closes $8.5M funding round
By AuntMinnie.com staff writers
Firm also notes board changes.
June 10, 2025
Money Pile 400
Radium-223 safety confirmed in long-term study
By Erik L. Ridley
At ASCO 2025, researchers shared data on the long-term safety of Ra-223 treatments for metastatic castration-resistant prostate cancer.
June 2, 2025
Pxl 20250531 175048475~2
Clarity highlights first patient imaged in Amplify trial
By AuntMinnie.com staff writers
Clarity Pharmaceuticals has imaged the first patient in its phase III Amplify trial at XCancer in Omaha, NE.
May 29, 2025
Prostate Cancer 3 D Rendering 400 (1)
ITM forges $263M debt financing agreement
By AuntMinnie.com staff writers
Isotope Technologies Munich (ITM) has entered into a debt financing agreement for up to $262.5 million.
May 28, 2025
Isotopes1
ISMRM: AI spots ischemic heart disease on low GBCA dose images
By Erik L. Ridley
An AI-based framework was highly accurate for detecting myocardial ischemia, even on images acquired with 90% less gadolinium.
May 14, 2025
Representative stress perfusion CMR case with 80% contrast dose reduction. Pixel-wise MBF maps and AHA 16-segment bull's eye plots are shown for full-dose and reduced-dose acquisitions. When analyzed using the proposed MST deep learning method, the reduced-dose data closely matches the full-dose data across basal, mid, and apical slices. In contrast, Fermi-deconvolution shows good agreement in apical and mid slices but overestimates MBF in some basal segments, indicating reduced accuracy under low-dose conditions. Image courtesy of the ISMRM.
FDA clears GE's new dual-head SPECT/CT system
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has cleared GE HealthCare's (GEHC) new dual-head SPECT/CT system, Aurora.
May 5, 2025
Gehc
Controversy clouds nuclear medicine bill
By Will Morton
Radiology societies and patient advocates are at odds over a bill in the U.S. Congress.
May 1, 2025
Congress
ARRS: 'Neurotheranostics' may be new frontier for nuclear medicine
By Will Morton
Advances in brain PET imaging combined with new treatments for Alzheimer’s have given rise to a new concept of "neurotheranostics."
April 29, 2025
A conceptual framework for neurotheranostics.
ARRS: Rib uptake evaluation on F-18 DCFPyL PET/CT presents challenges
By Maryam Payne
Evaluating increased rib uptake on F-18 DCFPyL PET/CT in prostate cancer patients may lead to false positives.
April 28, 2025
Pet Ct Machine
Page 1 of 437
Next Page